Immunis
Laguna Beach, US · Delaware corporation · 1 known investors
Founders & leadership
HK
Hans KeirsteadFounder
GN
Gabriel NistorNamed on SEC filing
Board
TK
Takahide KodaBoard director
DK
Daniel KraftBoard director
Investors · 1
Reported raises · per SEC filings
Form D private placements$32.4M disclosed across 2 rounds · 2024–2026
▶$12MraisedJun 2026 · 12 investors · BiotechnologyRule 506(b)
▶$12MraisedJun 2026 · 12 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Takahide KodaDirector
- Hans KeirsteadExecutive Officer, Director
- Daniel KraftDirector
- Gabriel NistorExecutive Officer
- Offering amount
- $12M
- Amount sold
- $12M
- Minimum investment
- $50K
- First sale
- May 2026
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$20.4MraisedOct 2024 · 27 investors · BiotechnologyRule 506(b)
▶$20.4MraisedOct 2024 · 27 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Gabriel NistorExecutive Officer
- Takahide KodaDirector
- Hans KeirsteadExecutive Officer, Director
- Daniel KraftDirector
- Offering amount
- $25M
- Amount sold
- $20.4M
- First sale
- Jun 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- Who founded Immunis?
- Immunis was founded by Hans Keirstead.
- Who are Immunis's investors?
- Immunis's investors include Remiges Ventures, Inc..
- How much funding has Immunis raised?
- Immunis has disclosed $32.4M raised across 2 rounds.
- Where is Immunis headquartered?
- Immunis is headquartered in Laguna Beach, US.